Science and Medicine Group

Instrument Business Outlook Volume 32 - Issue 24 3 Apr 2024

Report details
13 Figures
44 Tables

IBO Sales Indexes See Little Relief in Fourth Quarter and Full-Year 2023
- Analytical Instruments Sales Index
  - Calendar Year Fourth Quarter 2023
  - Calendar Year 2023
- Life Science Sales Index
  - Calendar Year Fourth Quarter 2023
  - Calendar Year 2023
- Calendar Year Fourth Quarter 2023 Results
  - End-Markets
  - Pharmaceutical and Biotech
  - Academia and Government
  - Applied
  - Industrial
  - Regions
  - China
  - Asia Pacific
  - Americas
  - Rest of World
  - Product Lines
  - Instruments
  - Consumables
- Calendar Year 2023 Results
  - End-Markets
  - Regions
  - Product Lines
- Outlook
A Disappointing US FY24 Budget for Science
- NIH Details
- FDA Details
- CDC Details
- DOE Details
- NSF Details
- EPA Details
- USDA Details
- NIST Details
- Dept. of Justice Details
Executive Briefing
- EU Advocate General Sides with Illumina
- Cell Culture Media Firm Biologos Sold
- Specac Expands
- Synthego’s Cell Engineering Business Becomes New Company
- Singular Genomics Announces Layoffs
Fourth Quarter Results: Bio-Rad Laboratories, Biotage, Bruker, MilliporeSigma…
- Bio-Rad Finishes 2023 with a Slight Decline
  - Q4
  - FYE
- Biotage Posts Growth Despite Challenges
  - Q4
  - FYE
- Bruker Forecasts a Solid 2024 Guidance
  - Q4
  - FYE
- Various Sales Deterrents Impact MilliporeSigma’s 2023 Revenue Performance
  - Q4
  - FYE
- Revvity’s 2023 Sales Performances Impacted by Declines in Select Businesses
  - Q4
  - FYE
IBO Stock Indexes Continue Positive Streak in March
- Laboratory Instruments and Products Stock Index
  - Diversified Instrumentation Stock Index
  - International Stocks
Market Profile: Solid Phase Extraction
- Leading Vendors
- Largest Markets
- Instrument Cost
Industry Watch
- R&D: RNA Sequencing
- Chemicals: New Database for Plastic Chemicals
- Clinical: Advances in At-Home Testing
Region Watch
- China: Global Pharma Deals
- EU: Microplastics Testing
- UK : Non-Health Engineering Biology Infrastructure
News
- Broad-Based Companies
  - Company Announcements
- Bioprocess Analysis
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Process Analysis
  - Company Announcements
  - Product Introductions
- Sequencing
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Life Science Consumables
  - Company Announcements
  - Gene-Based Analysis
  - Company Announcements
  - Product Introductions
  - Cell-Based Analysis
  - Company Announcements
  - Product Introductions
  - Protein-Based Analysis
  - Company Announcements
  - Product Introductions
Bottom Line

Attachments

IBO 040224 Issue.pdf

Instrument Business Outlook Volume 32 - Issue 24

3 Apr 2024

Request Access

Table of Contents

IBO Sales Indexes See Little Relief in Fourth Quarter and Full-Year 2023
- Analytical Instruments Sales Index
  - Calendar Year Fourth Quarter 2023
  - Calendar Year 2023
- Life Science Sales Index
  - Calendar Year Fourth Quarter 2023
  - Calendar Year 2023
- Calendar Year Fourth Quarter 2023 Results
  - End-Markets
  - Pharmaceutical and Biotech
  - Academia and Government
  - Applied
  - Industrial
  - Regions
  - China
  - Asia Pacific
  - Americas
  - Rest of World
  - Product Lines
  - Instruments
  - Consumables
- Calendar Year 2023 Results
  - End-Markets
  - Regions
  - Product Lines
- Outlook
A Disappointing US FY24 Budget for Science
- NIH Details
- FDA Details
- CDC Details
- DOE Details
- NSF Details
- EPA Details
- USDA Details
- NIST Details
- Dept. of Justice Details
Executive Briefing
- EU Advocate General Sides with Illumina
- Cell Culture Media Firm Biologos Sold
- Specac Expands
- Synthego’s Cell Engineering Business Becomes New Company
- Singular Genomics Announces Layoffs
Fourth Quarter Results: Bio-Rad Laboratories, Biotage, Bruker, MilliporeSigma and Revvity
- Bio-Rad Finishes 2023 with a Slight Decline
  - Q4
  - FYE
- Biotage Posts Growth Despite Challenges
  - Q4
  - FYE
- Bruker Forecasts a Solid 2024 Guidance
  - Q4
  - FYE
- Various Sales Deterrents Impact MilliporeSigma’s 2023 Revenue Performance
  - Q4
  - FYE
- Revvity’s 2023 Sales Performances Impacted by Declines in Select Businesses
  - Q4
  - FYE
IBO Stock Indexes Continue Positive Streak in March
- Laboratory Instruments and Products Stock Index
  - Diversified Instrumentation Stock Index
  - International Stocks
Market Profile: Solid Phase Extraction
- Leading Vendors
- Largest Markets
- Instrument Cost
Industry Watch
- R&D: RNA Sequencing
- Chemicals: New Database for Plastic Chemicals
- Clinical: Advances in At-Home Testing
Region Watch
- China: Global Pharma Deals
- EU: Microplastics Testing
- UK : Non-Health Engineering Biology Infrastructure
News
- Broad-Based Companies
  - Company Announcements
- Bioprocess Analysis
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Process Analysis
  - Company Announcements
  - Product Introductions
- Sequencing
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Life Science Consumables
  - Company Announcements
  - Gene-Based Analysis
  - Company Announcements
  - Product Introductions
  - Cell-Based Analysis
  - Company Announcements
  - Product Introductions
  - Protein-Based Analysis
  - Company Announcements
  - Product Introductions
Bottom Line